Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2) by Xiangyang Xue et al.
LECTURE PRESENTATION Open Access
Identification and characterization of novel B-cell
epitopes within EBV latent membrane protein 2
(LMP2)
Xiangyang Xue*, Shanli Zhu, Wenshu Li, Jun Chen, Qin Ou, Meixia Zheng, Wenci Gong, Lifang Zhang
From Institut Pasteur International Network Annual Scientific Meeting
Hong Kong. 22-23 November 2010
The purpose of this study was to screen and identify the
linear B cell epitopes of Epstein-Barr virus (EBV) latent
membrane protein 2 (LMP2). The secondary structure
and the surface properties of EBV LMP2A protein were
analyzed. Then, the peptides with good hydrophilicity,
high accessibility and flexibility and strong antigenicity
were chosen and average antigenicity index (AI) of epi-
tope peptide was further investigated. Three peptides
were selected as potential linear B cell epitopes. The
location and the sequence of amino acid were 199-209
(RIEDPPFNSLL), 318-322 (TLNLT) and 381-391
(KSLSSTEFIPN), respectively. The genes encoding
potential B cell epitope were cloned and expressed in
E. coli system. The immune sera of above different purified
fusion proteins were obtained from BLAB/c mice by sub-
cutaneously immunization for three times. Western blot
showed that these epitope recombinant proteins could be
recognized by the serum antibodies against the whole
LMP2 of EBV obtained from nasopharyngeal carcinoma
(NPC). Indirect ELISA measured the reactivity of individual
sera from 196 NPC patients, 44 infectious mononucleosis
(IM) and 108 healthy individuals to these epitope-fused
proteins indicated that NPC patients were significantly
higher compared with IM and healthy individuals (P<0.05).
In addition, all the immune sera of peptide-fused proteins
could response to native LMP2A antigen obtained from
the EBV prototype strain, B95-8 cells. IFA confirmed that
the recognition of the specific antibodies induced by the
immune sera of epitope peptide-fused proteins was intra-
cellular regions of LMP2A. These results demonstrated
that these three predictive epitopes not only were immuno-
dominant B-cell epitopes of LMP2A, but also may be
potential targets for application in the design of diagnostic
tools.
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